Atazanavir (300 mg) boosted by ritonavir (100 mg) is the preferred third drug in pregnancy. However, there is still discordance on atazanavir dose increase during the third trimester.

Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients

CALCAGNO, Andrea
Co-first
;
SIMIELE, MARCO;D'AVOLIO, ANTONIO;TRENTINI, Laura;DI PERRI, Giovanni;BONORA, Stefano
Last
2017-01-01

Abstract

Atazanavir (300 mg) boosted by ritonavir (100 mg) is the preferred third drug in pregnancy. However, there is still discordance on atazanavir dose increase during the third trimester.
2017
72
11
3163
3166
Focà, Emanuele; Calcagno, Andrea; Bonito, Andrea; Simiele, Marco; Domenighini, Elisabetta; D'Avolio, Antonio; Quiros Roldan, Eugenia; Trentini, Laura;...espandi
File in questo prodotto:
File Dimensione Formato  
10.1093@jac@dkx274.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 265.23 kB
Formato Adobe PDF
265.23 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1660055
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact